Functional differences and interactions between the escherichia coli type III secretion system effectors NleH1 and NleH2

Thanh H. Pham, Xiaofei Gao, Karen Tsai, Rachel Olsen, Fengyi Wan, Philip R. Hardwidge

Research output: Contribution to journalArticle

Abstract

The human pathogens enterohemorrhagic and enteropathogenic Escherichia coli (EHEC and EPEC), as well as the related mouse pathogen Citrobacter rodentium, utilize a type III secretion system (T3SS) to inject multiple effector proteins into host cells. The E. coli O157:H7 strain EDL933 carries two copies of non-locus of enterocyte effacement (LEE)-encoded protein H, designated NleH1 and NleH2, both of which bind to the human ribosomal protein S3 (RPS3), a subunit of NF-κB transcriptional complexes. In this study, we describe significant functional differences between NleH1 and NleH2 in their ability to regulate the host NF-κB pathway. We show that the EHEC and EPEC NleH effectors are functionally equivalent in their ability to affect RPS3 nuclear translocation. NleH1, but not NleH2, inhibited NF-κB activity without altering the kinetics of IκBα phosphorylation/degradation. We also determined that the class I PSD-95/Disc Large/ZO-1 (PDZ)-binding domain of NleH was important for its activity in the NF-κB pathway. In addition to binding RPS3, we found that NleH1 and NleH2 are able to bind to each other in vitro and in vivo, suggesting an additional mechanism by which the E. coli NleH effectors may regulate the extent and duration of NF-κB activation after their T3SS-dependent translocation. We also performed mouse infection experiments and established that mouse mortality and Citrobacter colonization were reduced in mice infected with ΔnleH. Complementing ΔnleH with NleH1 restored Citrobacter virulence and colonization to wild-type levels, whereas complementing with NleH2 reduced them. Taken together, our data show that NleH1 and NleH2 have pronounced functional differences in their ability to alter host transcriptional responses to bacterial infection.

Original languageEnglish (US)
Pages (from-to)2133-2140
Number of pages8
JournalInfection and Immunity
Volume80
Issue number6
DOIs
StatePublished - Jun 2012

Fingerprint

Citrobacter
Escherichia coli
Enterohemorrhagic Escherichia coli
Enteropathogenic Escherichia coli
Citrobacter rodentium
Escherichia coli O157
Enterocytes
Bacterial Infections
Virulence
Carrier Proteins
Proteins
Phosphorylation
Mortality
Type III Secretion Systems
Infection
ribosomal protein S3
human RPS3 protein
In Vitro Techniques

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Parasitology
  • Infectious Diseases

Cite this

Functional differences and interactions between the escherichia coli type III secretion system effectors NleH1 and NleH2. / Pham, Thanh H.; Gao, Xiaofei; Tsai, Karen; Olsen, Rachel; Wan, Fengyi; Hardwidge, Philip R.

In: Infection and Immunity, Vol. 80, No. 6, 06.2012, p. 2133-2140.

Research output: Contribution to journalArticle

Pham, Thanh H. ; Gao, Xiaofei ; Tsai, Karen ; Olsen, Rachel ; Wan, Fengyi ; Hardwidge, Philip R. / Functional differences and interactions between the escherichia coli type III secretion system effectors NleH1 and NleH2. In: Infection and Immunity. 2012 ; Vol. 80, No. 6. pp. 2133-2140.
@article{f776741cbd58432e88de6c3fd9805ce9,
title = "Functional differences and interactions between the escherichia coli type III secretion system effectors NleH1 and NleH2",
abstract = "The human pathogens enterohemorrhagic and enteropathogenic Escherichia coli (EHEC and EPEC), as well as the related mouse pathogen Citrobacter rodentium, utilize a type III secretion system (T3SS) to inject multiple effector proteins into host cells. The E. coli O157:H7 strain EDL933 carries two copies of non-locus of enterocyte effacement (LEE)-encoded protein H, designated NleH1 and NleH2, both of which bind to the human ribosomal protein S3 (RPS3), a subunit of NF-κB transcriptional complexes. In this study, we describe significant functional differences between NleH1 and NleH2 in their ability to regulate the host NF-κB pathway. We show that the EHEC and EPEC NleH effectors are functionally equivalent in their ability to affect RPS3 nuclear translocation. NleH1, but not NleH2, inhibited NF-κB activity without altering the kinetics of IκBα phosphorylation/degradation. We also determined that the class I PSD-95/Disc Large/ZO-1 (PDZ)-binding domain of NleH was important for its activity in the NF-κB pathway. In addition to binding RPS3, we found that NleH1 and NleH2 are able to bind to each other in vitro and in vivo, suggesting an additional mechanism by which the E. coli NleH effectors may regulate the extent and duration of NF-κB activation after their T3SS-dependent translocation. We also performed mouse infection experiments and established that mouse mortality and Citrobacter colonization were reduced in mice infected with ΔnleH. Complementing ΔnleH with NleH1 restored Citrobacter virulence and colonization to wild-type levels, whereas complementing with NleH2 reduced them. Taken together, our data show that NleH1 and NleH2 have pronounced functional differences in their ability to alter host transcriptional responses to bacterial infection.",
author = "Pham, {Thanh H.} and Xiaofei Gao and Karen Tsai and Rachel Olsen and Fengyi Wan and Hardwidge, {Philip R.}",
year = "2012",
month = "6",
doi = "10.1128/IAI.06295-11",
language = "English (US)",
volume = "80",
pages = "2133--2140",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "6",

}

TY - JOUR

T1 - Functional differences and interactions between the escherichia coli type III secretion system effectors NleH1 and NleH2

AU - Pham, Thanh H.

AU - Gao, Xiaofei

AU - Tsai, Karen

AU - Olsen, Rachel

AU - Wan, Fengyi

AU - Hardwidge, Philip R.

PY - 2012/6

Y1 - 2012/6

N2 - The human pathogens enterohemorrhagic and enteropathogenic Escherichia coli (EHEC and EPEC), as well as the related mouse pathogen Citrobacter rodentium, utilize a type III secretion system (T3SS) to inject multiple effector proteins into host cells. The E. coli O157:H7 strain EDL933 carries two copies of non-locus of enterocyte effacement (LEE)-encoded protein H, designated NleH1 and NleH2, both of which bind to the human ribosomal protein S3 (RPS3), a subunit of NF-κB transcriptional complexes. In this study, we describe significant functional differences between NleH1 and NleH2 in their ability to regulate the host NF-κB pathway. We show that the EHEC and EPEC NleH effectors are functionally equivalent in their ability to affect RPS3 nuclear translocation. NleH1, but not NleH2, inhibited NF-κB activity without altering the kinetics of IκBα phosphorylation/degradation. We also determined that the class I PSD-95/Disc Large/ZO-1 (PDZ)-binding domain of NleH was important for its activity in the NF-κB pathway. In addition to binding RPS3, we found that NleH1 and NleH2 are able to bind to each other in vitro and in vivo, suggesting an additional mechanism by which the E. coli NleH effectors may regulate the extent and duration of NF-κB activation after their T3SS-dependent translocation. We also performed mouse infection experiments and established that mouse mortality and Citrobacter colonization were reduced in mice infected with ΔnleH. Complementing ΔnleH with NleH1 restored Citrobacter virulence and colonization to wild-type levels, whereas complementing with NleH2 reduced them. Taken together, our data show that NleH1 and NleH2 have pronounced functional differences in their ability to alter host transcriptional responses to bacterial infection.

AB - The human pathogens enterohemorrhagic and enteropathogenic Escherichia coli (EHEC and EPEC), as well as the related mouse pathogen Citrobacter rodentium, utilize a type III secretion system (T3SS) to inject multiple effector proteins into host cells. The E. coli O157:H7 strain EDL933 carries two copies of non-locus of enterocyte effacement (LEE)-encoded protein H, designated NleH1 and NleH2, both of which bind to the human ribosomal protein S3 (RPS3), a subunit of NF-κB transcriptional complexes. In this study, we describe significant functional differences between NleH1 and NleH2 in their ability to regulate the host NF-κB pathway. We show that the EHEC and EPEC NleH effectors are functionally equivalent in their ability to affect RPS3 nuclear translocation. NleH1, but not NleH2, inhibited NF-κB activity without altering the kinetics of IκBα phosphorylation/degradation. We also determined that the class I PSD-95/Disc Large/ZO-1 (PDZ)-binding domain of NleH was important for its activity in the NF-κB pathway. In addition to binding RPS3, we found that NleH1 and NleH2 are able to bind to each other in vitro and in vivo, suggesting an additional mechanism by which the E. coli NleH effectors may regulate the extent and duration of NF-κB activation after their T3SS-dependent translocation. We also performed mouse infection experiments and established that mouse mortality and Citrobacter colonization were reduced in mice infected with ΔnleH. Complementing ΔnleH with NleH1 restored Citrobacter virulence and colonization to wild-type levels, whereas complementing with NleH2 reduced them. Taken together, our data show that NleH1 and NleH2 have pronounced functional differences in their ability to alter host transcriptional responses to bacterial infection.

UR - http://www.scopus.com/inward/record.url?scp=84863812507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863812507&partnerID=8YFLogxK

U2 - 10.1128/IAI.06295-11

DO - 10.1128/IAI.06295-11

M3 - Article

C2 - 22451523

VL - 80

SP - 2133

EP - 2140

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 6

ER -